Total Funding
55
47
Total FundingDebt Financing raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
52623
AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care.
David Olsen: Vice President, Quality Assurance, Regulatory and Clinical Affairs
Rick Valencia: Chairman & CEO (WaveForm)Past Role: Qualcomm Life, President & Founder
About the Company
AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care. The company’s products feature WaveSense, a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions.
Zero-Click™, the WaveSense diabetes data management system, was designed to simplify data download. WaveSense and Zero-Click consist of six FDA-cleared products and are protected by a suite of more than 160 patents worldwide.
